-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FV91VomzcfF26vHsjKWjpkSHFBHXWDovpNSbsmTzinTWa6TgiwuLjg7XVre1ex0Y Mmpl6Vg0tjukcmf3Z1N7pw== 0000950135-03-005929.txt : 20031205 0000950135-03-005929.hdr.sgml : 20031205 20031205101944 ACCESSION NUMBER: 0000950135-03-005929 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031204 ITEM INFORMATION: Other events FILED AS OF DATE: 20031205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HYBRIDON INC CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 031039343 BUSINESS ADDRESS: STREET 1: 345 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6176795500 MAIL ADDRESS: STREET 1: 345 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 8-K 1 b48636hye8vk.txt HYBRIDON, INC. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ---------- Date of Report (Date of earliest event reported): December 4, 2003 HYBRIDON, INC. - -------------------------------------------------------------------------------- (Exact name of Registrant as Specified in its Charter) Delaware 0-027352 04-3072298 -------- -------- ---------- (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No.) 345 Vassar Street, Cambridge, Massachusetts 02139 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) Zip Code) Registrant's telephone number, including area code: (617) 679-5500 Not Applicable - -------------------------------------------------------------------------------- (Former Name or Former Address if Changed Since Last Report) ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE On December 4, 2003, Hybridon, Inc. announced the results of a special meeting of stockholders held earlier that day at which a majority of stockholders approved amendments to Hybridon's Restated Certificate of Incorporation. At the meeting, holders of approximately 98% of the Company's Series A Preferred Stock and holders of over 68% of the Common Stock outstanding voted their shares in favor of the amendments. Hybridon also announced that its Common Stock would begin trading on the American Stock Exchange beginning at 9:30 a.m. ET on December 5, 2003 under the trading symbol "HBY". The approved amendments reduce the per share liquidation preference of the Company's Series A Preferred Stock from $100 to $1, reduce the annual dividend rate on the Company's Series A Preferred Stock from 6.5% to 1% and provide that during the period from December 4, 2003 to February 2, 2004, holders of Series A Preferred Stock will be able to convert their shares of Series A Preferred Stock into a number of shares of Common Stock that is 25% greater than the number of shares that would otherwise have been issuable upon conversion of the Series A Preferred Stock. In addition, holders of Series A Preferred Stock have agreed to convert at least 46.3% of the Series A Preferred Stock outstanding into Common Stock at the improved conversion rate. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 5, 2003 HYBRIDON, INC. /s/ Robert G. Andersen ------------------------------------- Robert G. Andersen Chief Financial Officer and Vice President of Operations -----END PRIVACY-ENHANCED MESSAGE-----